PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 42 filers reported holding PLX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,000 | -85.3% | 29,962 | -43.6% | 0.00% | – |
| Q2 2022 | $129,000 | -82.2% | 53,127 | -70.4% | 0.00% | -100.0% |
| Q1 2022 | $724,000 | -68.1% | 179,227 | -36.8% | 0.00% | -60.0% |
| Q4 2021 | $2,271,000 | -44.9% | 283,517 | +32.7% | 0.01% | -50.0% |
| Q3 2021 | $4,124,000 | +1394.2% | 213,655 | +968.3% | 0.01% | +900.0% |
| Q2 2021 | $276,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |